636 results on '"Timm, H."'
Search Results
2. Arteriovenous Oscillometric Plethysmography for Fistula Functional Testing
- Author
-
Veit Busch, Joachim Streis, Sandra Müller, Niklas Mueller, Felix S. Seibert, Thomas Felderhoff, and Timm H. Westhoff
- Subjects
arteriovenous fistula ,dialysis ,plethysmography ,pulse wave analysis ,pulse wave velocity ,Dermatology ,RL1-803 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Introduction: The aim of the presented prospective observational study was to evaluate the effect of fistula flow on peripheral wave morphology and pulse wave velocity by means of the oscillometric Vicorder®-device with the purpose of fistula surveillance. Methods: Digitized and normalized curves of 53 haemodialysis patients at the fistula and non-fistula arm were analysed. Slope parameters and the areas under the curve of characteristic sections of pulse waves as well as the power spectrum of the pulse waves and their first and second derivatives were computed. Furthermore, the amplitude of volumetric change (AMP) was assessed. Duplex sonography served as a reference method. Results: In the comprehensive set of novel pulse wave parameters significant inter-arm differences were demonstrated and a significant delay of the systolic maximum at the fistula arm in comparison to the non-fistula arm (204 ± 3.4 vs. 162 ± 5.3 ms, p < 0.001) was proven. Unexpectedly, pulse wave velocity apparently did not differ between both arms (7.85 vs. 8.05 m/s at the fistula/non-fistula side, p = 0.942). The inter-arm differences of the slope parameters were more pronounced in forearm than in upper arm fistulas. Finally, we showed that the inter-arm difference of AMP correlated with volume flow (r = 0.326 with p = 0.017). Conclusion: Pulse waves as assessed by oscillometric pulse wave analysis have distinct features at fistula and non-fistula arms. This is due to enhanced arteriovenous flow, i.e. in both the brachial artery and the fistula vein. The analysis of those alterations has the potential to assess fistula function.
- Published
- 2024
- Full Text
- View/download PDF
3. Prevalence of masked hypertension in attended versus unattended office blood pressure measurement
- Author
-
Sebastian Bertram, Frederic Bauer, Roni Shadi, Maximilian Seidel, Adrian Doevelaar, Felix Seibert, Nina Babel, and Timm H. Westhoff
- Subjects
masked hypertension ,office blood pressure ,unattended blood pressure measurement ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract There is a controversial debate regarding whether unattended blood pressure (BP) measurement should be regarded as the new gold standard of office BP measurement. Unattended BP measurement eliminates the white‐coat effect and reduces external influences on the patient. On the other hand, it might underestimate real‐life BP. The present study compares the prevalence of masked hypertension using attended versus unattended office BP measurements. We performed a cross‐sectional study on 213 patients in a general practitioner's outpatient clinic and compared attended and unattended office BP with 24h‐ambulatory BP monitoring (24h‐ABPM). Masked hypertension was defined as pressure ≥135/85 mmHg in daytime ABPM with office systolic BP
- Published
- 2024
- Full Text
- View/download PDF
4. Urinary calprotectin as a diagnostic tool for detecting significant bacteriuria
- Author
-
Sabina Waldecker-Gall, Christoph B. Waldecker, Nina Babel, Xenofon Baraliakos, Felix Seibert, and Timm H. Westhoff
- Subjects
Calprotectin ,Bacteriuria ,Biomarker ,Urinary tract infection ,Medicine ,Science - Abstract
Abstract Pyuria in dipstick examination serves as the most widespread screening tool for urinary tract infections (UTI). The absence of pyuria, however, does not exclude UTI. We investigated the diagnostic value of urinary calprotectin, a mediator protein of the innate immune system, which is released by leukocytes, for the detection of UTI and compared it with dipstick pyuria. Since even low numbers of leukocytes in the urine significantly increase urinary calprotectin concentrations, calprotectin might be a more sensitive marker than pyuria detected by dipstick. All 162 patients were prospectively included and underwent a urine dipstick, urine culture, quantification of proteinuria and determination of calprotectin in the urine. Urinary calprotectin was determined using an enzyme-linked immunosorbent assay (ELISA). UTI was defined as urine cultures with detection of one or a maximum of two uropathogenic bacteria with ≥ 105 colony-forming units per millilitre (CFU/ml). Exclusion criteria were acute kidney injury, chronic renal insufficiency and tumors of the urinary tract. 71 (43.8%) patients had a UTI. Of the 91 patients without UTI, 23 had a contamination and 19 had evidence of ≥ 105 CFU/ml considered to be asymptomatic bacteriuria. The median calprotectin concentration in patients with UTI and pyuria was significantly higher than in patients with UTI and without pyuria (5510.4 vs. 544.7 ng/ml). In ROC analyses, calprotectin revealed an area under the curve (AUC) of 0.70 for the detection of significant bacteriuria. Pyuria in dipstick examinations provided an AUC of 0.71. There was no significant difference between these AUCs in the DeLong test (p = 0.9). In patients with evidence of significant bacteriuria but without pyuria, a significantly higher calprotectin concentration was measured in the urine than in patients with neither pyuria nor UTI (544.7 ng/ml vs 95.6 ng/ml, p = 0.029). Urinary calprotectin is non-inferior to dipstick pyuria in the detection of UTI.
- Published
- 2024
- Full Text
- View/download PDF
5. Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
- Author
-
Moritz Anft, Panagiota Zgoura, Sarah Skrzypczyk, Michael Dürr, Richard Viebahn, Timm H. Westhoff, Ulrik Stervbo, and Nina Babel
- Subjects
immunity ,Immunosuppression ,kidney transplantation ,tacrolimus ,T cells ,Specialties of internal medicine ,RC581-951 - Abstract
BackgroundLCP-Tacro [LCPT], a novel once-daily, extended-release formulation of tacrolimus, has a reduced Cmax with comparable AUC exposure, requiring a ∼30% dose reduction in contrast to immediate-release tacrolimus (IR-Tac). Once-daily LCPT in de novo kidney transplantation has a comparable efficacy and safety profile to that of IR-Tac with advantages in bioavailability and absorption. The present investigation intends to analyze the effects of conversion from IR-Tac to LCPT on phenotype and function of T-cells and B-cells.Methods16 kidney transplant patients treated by triple standard immunosuppression with a stable graft function undergoing a switch from IR-Tac to LCPT were included in this observational prospective study. We measured the main immune cell types and performed an in-depth characterization of B cell, dendritic cells and T cells including regulatory T cells of the patients before, 4 and 8 weeks after IR-Tac to LCPT conversion using multi-parameter fl ow cytometry. Additionally, we analyzed T cells by assessing third-party antigens (Tetanus Diphtheria, TD)-reactive T cells, which could be analyzed by restimulation with tetanus vaccine.ResultsOverall, we found no significant alterations following LCPT conversion for the most immune cell populations with a few cell populations showing transient quantitative increase. Thus, 4 weeks after conversion, more regulatory T cells could be measured in the patients with a significant shift from memory to naïve Tregs. Furthermore, we found a transient B cell expansion 4 weeks after conversion from IR-Tac to LCPT. There were no changes in the percentage of other basic immune cell types and the antigen-reactive T cells were also not altered after changing the medication to LCP-tacrolimus.ConclusionHere, we demonstrate first insights into the immune system changes occurred under IR-Tac to LCPT conversion therapy in kidney transplant patients. While phenotypic and functional characteristics of the most immune cell populations did not change, we could observe an a transient expansion of regulatory T cells in peripheral blood following IR-Tac to LCTP conversion, which might additionally contribute to the overall immunosuppressive effect.
- Published
- 2024
- Full Text
- View/download PDF
6. Propionic acid supplementation promotes the expansion of regulatory T cells in patients with end-stage renal disease but not in renal transplant patients
- Author
-
Moritz Anft, Fabian Meyer, Sirin Czygan, Felix S. Seibert, Benjamin J. Rohn, Fotios Tsimas, Richard Viebahn, Timm H. Westhoff, Ulrik Stervbo, Nina Babel, and Panagiota Zgoura
- Subjects
immunity ,immunosuppression ,kidney transplantation ,propionate ,regulatory T cells ,Specialties of internal medicine ,RC581-951 - Abstract
In a previous study, we showed an anti-inflammatory effect of propionic acid supplementation in dialysis patients. The present study intends to analyze the effect of propionic acid on the chronic inflammatory state and T-cell composition in kidney transplant patients compared to dialysis patients. A total of 10 dialysis patients and 16 kidney transplant patients under immunosuppressive standard triple immunosuppressive therapy received 2 × 500 mg propionic acid per day for 30 days. The cellular immune system was analyzed before and after the propionic acid supplementation and 30–90 days thereafter as a follow-up. We measured the main immune cell types and performed an in-depth characterization of T cells including regulatory T cells (Tregs), B cells, and dendritic cells. In addition, we assessed the functional activity and antigenic responsiveness by analysis of third-party antigen-specific T cells after their stimulation by recall (tetanus diphtheria vaccine) antigen. In dialysis patients, we observed an expansion of CD25highCD127− Tregs after propionic acid intake. In contrast, the same supplementation did not result in any expansion of Tregs in transplant patients under immunosuppressive therapy. We also did not observe any changes in the frequencies of the main immune cell subsets except for CD4+/CD8+ distribution with an increase of CD4+ T cells and decrease of CD8+ T cells in the transplant population. Our data suggest that dietary supplements containing propionate might have a beneficial effect decreasing systemic inflammation in dialysis patients through Treg expansion. However, this effect was not observed in transplant patients, which could be explained by counteracting effect of immunosuppressive drugs preventing Treg expansion.
- Published
- 2024
- Full Text
- View/download PDF
7. Impact of the COVID-19 pandemic on hospital admission rates for arterial hypertension and coronary heart disease: a German database study
- Author
-
Benjamin Sasko, Marios Matiakis, Felix S. Seibert, Nikolaos Pagonas, Hans-Jörg Hippe, Nina Babel, Christian Ukena, and Timm H. Westhoff
- Subjects
endothelial dysfunction ,COVID-19 ,coronary artery disease ,acute myocardial infarction ,hospitalisation ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundDuring the SARS-CoV-2 pandemic it was speculated that the virus might be associated with a persistent increase of cardiovascular risk. The present study compares pre- and post-pandemic hospital admission rates for hypertension and coronary artery disease.MethodsSystematic multicentric retrospective cohort analysis of 57.795 hospital admissions in an urban region in Germany during two different periods (pre-pandemic 01–06/2019 vs. post-pandemic era 01–06/2023). Information on hospital admissions for arterial hypertension, chronic coronary syndrome, unstable angina pectoris and acute myocardial infarction were extracted from the hospitals data systems. Additionally, six comorbidities and performed coronary interventions were monitored.ResultsCompared to the pre-pandemic era, there was no increase in hospitalizations for arterial hypertension (516 vs. 483, −6.8%, p = 0.07) or myocardial infarction (487 vs. 349, −23.8%, p
- Published
- 2024
- Full Text
- View/download PDF
8. Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
- Author
-
Krystallenia Paniskaki, Sarah Goretzki, Moritz Anft, Margarethe J. Konik, Klara Lechtenberg, Melanie Vogl, Toni L. Meister, Stephanie Pfaender, Markus Zettler, Jasmin Jäger, Sebastian Dolff, Timm H. Westhoff, Hana Rohn, Ursula Felderhoff-Mueser, Ulrik Stervbo, Oliver Witzke, Christian Dohna-schwake, and Nina Babel
- Subjects
SARS-CoV-2 ,T cells ,Neutralizing antibodies ,Adaptive immunity ,Children ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Cross-reactive cellular and humoral immunity can substantially contribute to antiviral defense against SARS-CoV-2 variants of concern (VOC). While the adult SARS-CoV-2 cellular and humoral immunity and its cross-recognition potential against VOC is broadly analyzed, similar data regarding the pediatric population are missing. In this study, we perform an analysis of the humoral and cellular SARS-CoV-2 response immune of 32 convalescent COVID-19 children (children), 27 convalescent vaccinated adults(C + V+) and 7 unvaccinated convalescent adults (C + V-). Similarly to adults, a significant reduction of cross-reactive neutralizing capacity against delta and omicron VOC was observed 6 months after SARS-CoV-2 infection. While SAR-CoV-2 neutralizing capacity was comparable among children and C + V- against all VOC, children demonstrated as expected an inferior humoral response when compared to C + V+. Nevertheless, children generated SARS-CoV-2 reactive T cells with broad cross-recognition potential. When compared to V + C+, children presented even comparable frequencies of WT-reactive CD4 + and CD8 + T cells with high avidity and functionality. Taking into consideration the limitations of study - unknown disease onset for 53% of the asymptomatic pediatric subjects, serological detection of SARS-CoV-2 infection-, our results suggest that following SARS-CoV-2 infection children generate a humoral SARS-CoV-2 response with neutralizing potential comparable to unvaccinated COVID-19 convalescent adults as well a sustained SARS-CoV-2 cellular response cross-reactive to VOC.
- Published
- 2023
- Full Text
- View/download PDF
9. Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
- Author
-
Paniskaki, Krystallenia, Goretzki, Sarah, Anft, Moritz, Konik, Margarethe J., Lechtenberg, Klara, Vogl, Melanie, Meister, Toni L., Pfaender, Stephanie, Zettler, Markus, Jäger, Jasmin, Dolff, Sebastian, Westhoff, Timm H., Rohn, Hana, Felderhoff-Mueser, Ursula, Stervbo, Ulrik, Witzke, Oliver, Dohna-schwake, Christian, and Babel, Nina
- Published
- 2023
- Full Text
- View/download PDF
10. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019
- Author
-
Doevelaar, Adrian A. N., Bachmann, Martin, Hölzer, Bodo, Seibert, Felix S., Rohn, Benjamin J., Zgoura, Panagiota, Witzke, Oliver, Dittmer, Ulf, Brenner, Thorsten, Paniskaki, Krystallenia, Yilmaz, Serap, Dittmer, Rita, Schneppenheim, Sonja, Wilhelm, Jochen, Stervbo, Ulrik, Babel, Nina, Budde, Ulrich, and Westhoff, Timm H.
- Published
- 2023
- Full Text
- View/download PDF
11. Oscillometric pulse wave analysis for detecting low flow arteriovenous fistula
- Author
-
Busch, Veit, Streis, Joachim, Müller, Sandra, Mueller, Niklas, Seibert, Felix S., Felderhoff, Thomas, and Westhoff, Timm H.
- Published
- 2023
- Full Text
- View/download PDF
12. Oscillometric pulse wave analysis for detecting low flow arteriovenous fistula
- Author
-
Veit Busch, Joachim Streis, Sandra Müller, Niklas Mueller, Felix S. Seibert, Thomas Felderhoff, and Timm H. Westhoff
- Subjects
Pulse wave analysis ,Haemodialysis, arteriovenous fistula ,Duplex sonography ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Background Pulse wave analysis may be useful to assess fistula function. We aimed to prospectively evaluate if convenient oscillometric devices are applicable to detect flow below 500 ml/min in a real life clinical setting. Methods Pulse waves were recorded ambilaterally with the vicorder® device at the brachial artery in 53 patients on haemodialysis with native fistula. Primary variables consisted of the mean slope between the systolic maximum and the diacrotic notch (Slope2), the sum of the mean slopes in the four characteristic sections of pulse waves (Slope∑) and the amplitude of relative volumetric change in the measuring cuff at the upper arm (AMP). Fistula flow was measured with the use of duplex sonography using a standardized approach. Results Parameter values above or below the median indicated measurement at the non-fistula side, with sensitivities/specificities of 0.79/0.79 (p
- Published
- 2023
- Full Text
- View/download PDF
13. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019
- Author
-
Adrian A. N. Doevelaar, Martin Bachmann, Bodo Hölzer, Felix S. Seibert, Benjamin J. Rohn, Panagiota Zgoura, Oliver Witzke, Ulf Dittmer, Thorsten Brenner, Krystallenia Paniskaki, Serap Yilmaz, Rita Dittmer, Sonja Schneppenheim, Jochen Wilhelm, Ulrik Stervbo, Nina Babel, Ulrich Budde, and Timm H. Westhoff
- Subjects
Medicine ,Science - Abstract
Abstract It has recently been shown that von Willebrand factor (VWF) multimers contribute to immunothrombosis in Coronavirus disease 2019 (COVID-19). Since COVID-19 is associated with an increased risk of autoreactivity, the present study investigates, whether the generation of autoantibodies to ADAMTS13 contributes to this finding. In this observational prospective controlled multicenter study blood samples and clinical data of patients hospitalized for COVID-19 were collected from April to November 2020. The study included 156 individuals with 90 patients having confirmed COVID-19 of mild to critical severity. 30 healthy individuals and 36 critically ill ICU patients without COVID-19 served as controls. ADAMTS13 antibodies occurred in 31 (34.4%) COVID-19 patients. Antibodies occurred more often in critically ill COVID-19 patients (55.9%) than non-COVID-19 ICU patients and healthy controls (5.6% and 6.7%; p < 0.001), respectively. Generation of ADAMTS13 antibodies in COVID-19 was associated with lower ADAMTS13 activity (56.5%, interquartile range (IQR) 21.25 vs. 71.5%, IQR 24.25, p = 0.0041), increased disease severity (severe or critical in 90% vs. 62.3%, p = 0.019), and a trend to higher mortality (35.5% vs. 18.6%, p = 0.077). Median time to antibody development was 11 days after first positive SARS-CoV-2-PCR specimen. Gel analysis of VWF multimers resembled the constellation in patients with TTP. The present study demonstrates for the first time, that generation of ADAMTS13 antibodies is frequent in COVID-19, associated with lower ADAMTS13 activity and increased risk of an adverse disease course. These findings provide a rationale to include ADAMTS13 antibodies in the diagnostic workup of SARS-CoV-2 infections.
- Published
- 2023
- Full Text
- View/download PDF
14. Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
- Author
-
Sabina Waldecker-Gall, Felix Seibert, Sebastian Bertram, Adrian Doevelaar, Jürgen Braun, Xenofon Baraliakos, Nina Babel, Christoph Waldecker, Linda Scharow, Nikolaos Pagonas, and Timm H. Westhoff
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Background: The mechanism explaining low cholesterol concentrations in chronic inflammatory rheumatic disease (CIRD) is incompletely understood. We hypothesized that chronic inflammation impairs the functionality of high-density lipoprotein (HDL), for example, by oxidative processes. Objectives: Assessment of oxidized HDL (HDL ox ), a marker of dysfunctional HDL, in newly diagnosed patients with CIRD before and after initiation of immunosuppressive therapy and comparison of HDL ox values of patients with CIRD to non-CIRD controls. Design: Prospective observational trial. Methods: The study was conducted on 44 newly diagnosed CIRD patients, who were initiated on immunosuppressive therapy (baseline). A total of 136 patients without CIRD served as control. Lipid profiles including HDL ox levels and C-reactive protein (CRP) were measured in both groups at baseline. In CIRD patients, measurements were repeated 12 weeks after baseline. Validated outcome tools for disease activity and function were assessed at baseline and 12 weeks. Results: A total of 33 (75%) patients with rheumatoid arthritis, 7(16%) with axial spondyloarthritis, and 4 (9%) with systemic lupus erythematosus were included. Groups were comparable for age and BMI. CIRD patients had higher HDL ox concentrations (1.57 versus 0.78, p = 0.02) and tended to have lower low-density lipoprotein cholesterol, HDL cholesterol, and cholesterol concentrations compared to controls. HDL ox (1.57 versus 1.4, p = 0.26) and CRP levels (2.1 versus 0.7 mg/dl, p
- Published
- 2023
- Full Text
- View/download PDF
15. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
- Author
-
Özcan, Fedai, Markau, Silke, Girndt, Matthias, Felten, Helmut, Hausberg, Martin, Brand, Marcus, Gerth, Jens, Bommer, Martin, Zschiedrich, Stefan, Schneider, Johanna, Elitok, Saban, Gawlik, Alexander, Schwenger, Vedat, Roeder, Maximilian, Radermacher, Jörg, Morgner, Anke, Herbst, Regina, von Auer, Charis, Völker, Linus A., Kaufeld, Jessica, Balduin, Gesa, Merkel, Lena, Kühne, Lucas, Eichenauer, Dennis A., Osterholt, Thomas, Hägele, Holger, Kann, Martin, Grundmann, Franziska, Kolbrink, Benedikt, Schulte, Kevin, Gäckler, Anja, Kribben, Andreas, Boss, Kristina, Potthoff, Sebastian A., Rump, Lars C., Schmidt, Tilman, Mühlfeld, Anja S., Schulmann, Karsten, Hermann, Matthias, Gaedeke, Jens, Sauerland, Kristin, Bramstedt, Jörn, Hinkel, Ulrich P., Miesbach, Wolfgang, Bauer, Frederic, Westhoff, Timm H., Bruck, Heike, Buxhofer-Ausch, Veronika, Müller, Tobias J., Wendt, Ralph, Harth, Ana, Schreiber, Adrian, Seelow, Evelyn, Tölle, Markus, Gohlisch, Christopher, Bieringer, Markus, Geuther, Gesa, Jabs, Wolfram J., Fischereder, Michael, von Bergwelt-Baildon, Anke, Schönermarck, Ulf, Knoebl, Paul, Menne, Jan, and Brinkkoetter, Paul T.
- Published
- 2023
- Full Text
- View/download PDF
16. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
- Author
-
Krystallenia Paniskaki, Margarethe J. Konik, Moritz Anft, Harald Heidecke, Toni L. Meister, Stephanie Pfaender, Adalbert Krawczyk, Markus Zettler, Jasmin Jäger, Anja Gaeckler, Sebastian Dolff, Timm H. Westhoff, Hana Rohn, Ulrik Stervbo, Carmen Scheibenbogen, Oliver Witzke, and Nina Babel
- Subjects
post-acute sequelae of COVID-19 ,PASC ,long COVID ,T cells ,BMI ,Microbiology ,QR1-502 - Abstract
The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19 (PASC) is not well explored, although a growing population of convalescent COVID-19 patients with manifestation of PASC is observed. We analyzed the SARS-CoV-2-specific immune response, via pseudovirus neutralizing assay and multiparametric flow cytometry in 40 post-acute sequelae of COVID-19 patients with non-specific PASC manifestation and 15 COVID-19 convalescent healthy donors. Although frequencies of SARS-CoV-2-reactive CD4+ T cells were similar between the studied cohorts, a stronger SARS-CoV-2 reactive CD8+ T cell response, characterized by IFNγ production and predominant TEMRA phenotype but low functional TCR avidity was detected in PASC patients compared to controls. Of interest, high avidity SARS-CoV-2-reactive CD4+ and CD8+ T cells were comparable between the groups demonstrating sufficient cellular antiviral response in PASC. In line with the cellular immunity, neutralizing capacity in PASC patients was not inferior compared to controls. In conclusion, our data suggest that PASC may be driven by an inflammatory response triggered by an expanded population of low avidity SARS-CoV-2 reactive pro-inflammatory CD8+ T cells. These pro-inflammatory T cells with TEMRA phenotype are known to be activated by a low or even without TCR stimulation and lead to a tissue damage. Further studies including animal models are required for a better understanding of underlying immunopathogensis. Summary: A CD8+ driven persistent inflammatory response triggered by SARS-CoV-2 may be responsible for the observed sequelae in PASC patients.
- Published
- 2023
- Full Text
- View/download PDF
17. Impact of the COVID-19 pandemic on hospital admission rates for arterial hypertension and coronary heart disease: a German database study
- Author
-
Sasko, Benjamin, primary, Matiakis, Marios, additional, Seibert, Felix S., additional, Pagonas, Nikolaos, additional, Hippe, Hans-Jörg, additional, Babel, Nina, additional, Ukena, Christian, additional, and Westhoff, Timm H., additional
- Published
- 2024
- Full Text
- View/download PDF
18. In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder
- Author
-
Thieme, Constantin J., Schulz, Malissa, Wehler, Patrizia, Anft, Moritz, Amini, Leila, Blàzquez-Navarro, Arturo, Stervbo, Ulrik, Hecht, Jochen, Nienen, Mikalai, Stittrich, Anna-Barbara, Choi, Mira, Zgoura, Panagiota, Viebahn, Richard, Schmueck-Henneresse, Michael, Reinke, Petra, Westhoff, Timm H., Roch, Toralf, and Babel, Nina
- Published
- 2022
- Full Text
- View/download PDF
19. The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension
- Author
-
Pagonas, Nikolaos, Vlatsas, Stergios, Bauer, Frederic, Seibert, Felix S, Sasko, B, Buschmann, I, Ritter, O, Kelesidis, Theodoros, and Westhoff, Timm H
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Cardiovascular ,Atherosclerosis ,Clinical Research ,Clinical Trials and Supportive Activities ,Prevention ,Hypertension ,6.7 Physical ,Evaluation of treatments and therapeutic interventions ,Adult ,Aged ,Biomarkers ,Blood Pressure ,Cholesterol ,HDL ,Exercise ,Female ,Germany ,Humans ,Isometric Contraction ,Lipoproteins ,HDL ,Male ,Middle Aged ,Oxidation-Reduction ,Prospective Studies ,Time Factors ,Treatment Outcome ,Aerobic exercise ,isometric exercise ,HDL function ,lipids ,hypertension ,Cardiovascular medicine and haematology - Abstract
BackgroundExercise training increases high-density lipoprotein (HDL) cholesterol, but its effect on HDL function is unclear. In hypertensives, exercise improves endothelial dysfunction, which is related to HDL function. In the present study, we assess for the first time the effects of different exercise modalities on two cell-free assays of HDL function.DesignThe study was conducted as a prospective randomized controlled trial in 75 hypertensive patients.MethodsPatients were randomized in three groups: (a) handgrip isometric training five times weekly; (b) placebo-handgrip; and (c) aerobic exercise training at least three times per week. HDL function was assessed in serum samples at baseline and after 12 weeks of training by two independent assays that determine the proinflammatory phenotype (haptoglobin content) of a specific amount of HDL (Haptoglobin-HDL [HPHDL]) and oxidized HDL (HDLox) as a measure of reduced antioxidant function of HDL. HDL function measures were normalized by the measures of a pooled control of sera from healthy participants and by HDL-C levels (normalized ratio, no units).ResultsAerobic exercise led to significant reduction of the HDLox from 0.99 ± 0.27 to 0.90 ± 0.29 (no units, p = 0.03). The HPHDL did not change in any training group. Changes of HDLox correlated with reduction of the systolic blood pressure only after aerobic exercise (R = 0.64, p = 0.03).ConclusionsAerobic but not isometric exercise improves the antioxidant function of HDL in patients with hypertension. This improvement correlates positively with reductions of blood pressure.
- Published
- 2019
20. Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
- Author
-
Ulrik Stervbo, Marc Van Bracht, Stathis Philippou, Nina Babel, and Timm H. Westhoff
- Subjects
COVID-19 ,SARS-CoV-2 ,vaccination ,mRNA-1273 ,myocarditis ,AIRR-Seq ,Medicine (General) ,R5-920 - Abstract
Vaccination of SARS-CoV-2 with BNT162b2 or mRNA-1273 both have a low incidence of induction of myocarditis. Here we report on utilizing adaptive immune receptor repertoire sequencing (AIRR-Seq) as a way to assess the specificity of tissue infiltrating immune cells.
- Published
- 2023
- Full Text
- View/download PDF
21. Association of plasma propionate concentration with coronary artery disease in a large cross-sectional study
- Author
-
Nikolaos Pagonas, Felix S. Seibert, Gerhard Liebisch, Maximillian Seidel, Theodoros Giannakopoulos, Benjamin Sasko, Oliver Ritter, Nina Babel, and Timm H. Westhoff
- Subjects
short chain fatty acids ,coronary artery disease ,propionate ,atherosclerosis ,microbiome ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundMicrobiome has been linked to the pathogenesis of coronary artery disease (CAD) but data providing direct evidence for an association of short-chain fatty acids (SCFA) with CAD are lacking. This study aimed to evaluate the role of propionate, the most important SCFA in patients with CAD.MethodsWe performed a cross-sectional study enrolling patients admitted for invasive coronary angiography in two university hospitals in Germany. Patients with known or suspected CAD and risk factors for cardiovascular disease were prospectively recruited. Blood sampling was performed after overnight fasting and before invasive procedures. Measurement of propionate was performed by liquid chromatography.ResultsThe study included 1,253 patients (median [IQR], 67 [58–76] years; 799 men [64%]). A total of 739 had invasively confirmed CAD with at least one coronary artery stenosis ≥50% and 514 had exclusion of CAD. CAD patients had significant lower levels of propionate (median 5.75 μM, IQR, 4.1–7.6) compared to the non-CAD groups 6.53 μM (4.6–8.6, p
- Published
- 2023
- Full Text
- View/download PDF
22. Impact of weather changes on hospital admissions for hypertension
- Author
-
Bauer, Frederic, Lindtke, Janine, Seibert, Felix, Rohn, Benjamin, Doevelaar, Adrian, Babel, Nina, Schlattmann, Peter, Bertram, Sebastian, Zgoura, Panagiota, and Westhoff, Timm H.
- Published
- 2022
- Full Text
- View/download PDF
23. The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea
- Author
-
Toma, Daniela, Bertram, Sebastian, Racovitan, Diana, Seidel, Maximilian, Doevelaar, Adrian, Seibert, Felix S., Rohn, Benjamin, Babel, Nina, Mühlberger, Dominic, Büchner, Nikolaus, Wang, Simon, and Westhoff, Timm H.
- Published
- 2022
- Full Text
- View/download PDF
24. Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
- Author
-
Seibert, Felix S., Blazquez-Navarro, Arturo, Hölzer, Bodo, Doevelaar, Adrian A. N., Nusshag, Christian, Merle, Uta, Morath, Christian, Zgoura, Panagiota, Dittmer, Rita, Schneppenheim, Sonja, Wilhelm, Jochen, Babel, Nina, Budde, Ulrich, and Westhoff, Timm H.
- Published
- 2022
- Full Text
- View/download PDF
25. Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
- Author
-
Bertram, Sebastian, Blazquez-Navarro, Arturo, Seidel, Maximilian, Hölzer, Bodo, Seibert, Felix S., Doevelaar, Adrian, Rohn, Benjamin, Zgoura, Panagiota, Witte-Lack, Alexandra, Skrzypczyk, Sarah, Scholten, David, Kisters, Klaus, Babel, Nina, and Westhoff, Timm H.
- Published
- 2022
- Full Text
- View/download PDF
26. Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
- Author
-
Sebastian Bertram, Arturo Blazquez-Navarro, Maximilian Seidel, Bodo Hölzer, Felix S. Seibert, Adrian Doevelaar, Benjamin Rohn, Panagiota Zgoura, Alexandra Witte-Lack, Sarah Skrzypczyk, David Scholten, Klaus Kisters, Nina Babel, and Timm H. Westhoff
- Subjects
Medicine ,Science - Abstract
Abstract Healthcare workers are at substantially increased risk for infection with SARS-CoV-2. Successful vaccination constitutes a crucial prerequisite to protect this group during the pandemic. Since post vaccination antibody monitoring is not standard of care in all healthcare institutions, data on risk factors of impaired vaccine induced immune response are urgently required. Moreover, there are no data on cellular immune responses in humoral low responders so far. Anti-SARS-CoV-2 spike IgG was assessed after vaccination with BNT162b2 in 1386 employees of three hospitals of a German healthcare provider. Concentrations were compared to those of 45 convalescent employees. Vaccine-induced cellular immunity was measured in employees with reduced humoral response by assessment of frequencies of SARS-CoV-2-reactive CD4+ and CD8+ T cell. Anti-SARS-CoV-2 spike IgG were detected in 99.9% of 1386 healthcare workers after completed vaccination. The median antibody concentration was significantly higher after vaccination than after infection with SARS-CoV-2 (p = 0.0001). 10 subjects (0.7%) generated an IgG concentration
- Published
- 2022
- Full Text
- View/download PDF
27. Impact of weather changes on hospital admissions for hypertension
- Author
-
Frederic Bauer, Janine Lindtke, Felix Seibert, Benjamin Rohn, Adrian Doevelaar, Nina Babel, Peter Schlattmann, Sebastian Bertram, Panagiota Zgoura, and Timm H. Westhoff
- Subjects
Medicine ,Science - Abstract
Abstract Blood pressure (BP) shows a seasonal variation with higher levels at lower temperatures. Many hypertensives, however, report on BP disturbances rather in association with acutely changing weather conditions than with absolute temperatures. To date, the impact of changing meteorological parameters on hypertensive episodes remains elusive. We performed a retrospective time series regression analysis on 203,703 patients in three hospitals in Germany between 2010 and 2018, of whom 7362 patients were admitted for hypertensive disease. Numbers of daily admissions for hypertension were associated with metereological data obtained from three nearby weather stations. Data comprised temperature (mean, maximal, minimal and range within 24 h), athmospheric pressure, and precipitation. Changes of these parameters were calculated over a two and three day period. There was an inverse correlation between maximal daily temperature and the number of admissions for hypertensive disease, which remained significant both after adjustment for seasonality and week day in a spline model and in a constrained distributed lag model. A decrease of maximal temperature by 5 °C was associated with a 3% increase of risk for admission for hypertension and vice versa. There were no significant effects of precipitation and athmospheric pressure on the number of admissions. With regard to all observed metereological parameters, neither the change within two, nor within three days was consistently associated with the number of daily admissions. High temperatures are associated with lower numbers of hypertensive episodes requiring hospital admission. In contrast to the subjective perception of many hypertensive patients, however, acutely changing weather conditions are not associated with a higher risk of hypertensive emergency.
- Published
- 2022
- Full Text
- View/download PDF
28. The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea
- Author
-
Daniela Toma, Sebastian Bertram, Diana Racovitan, Maximilian Seidel, Adrian Doevelaar, Felix S. Seibert, Benjamin Rohn, Nina Babel, Dominic Mühlberger, Nikolaus Büchner, Simon Wang, and Timm H. Westhoff
- Subjects
Medicine ,Science - Abstract
Abstract Improving sleep quality in patients with obstructive sleep apnea (OSA) by positive airway pressure therapy is associated with a decrease of blood pressure (BP). It remains elusive, whether treatment of sleep disturbances due to restless legs syndrome with symptomatic periodic limb movements in sleep (PLMS) affects BP as well. The present study provides first data on this issue. Retrospective study on patients undergoing polysomnography in a German University Hospital. Inclusion criteria were first diagnosis of restless legs syndrome with PLMS (PLM index ≥ 15/h and PLM arousal index ≥ 5/h) with subsequent initiation of levodopa/benserazide or dopamine agonists. Exclusion criterion was an initiation or change of preexisting positive airway pressure therapy between baseline and follow-up. BP and Epworth sleepiness scale were assessed at two consecutive polysomnographies. After screening of 953 PLMS data sets, 114 patients (mean age 62.1 ± 12.1 years) were included. 100 patients (87.7%) were started on levodopa/benserazide, 14 patients (12.2%) on dopamine agonists. Treatment was associated with significant reductions of PLM index (81.2 ± 65.0 vs. 39.8 ± 51.2, p
- Published
- 2022
- Full Text
- View/download PDF
29. Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
- Author
-
Felix S. Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, Adrian A. N. Doevelaar, Christian Nusshag, Uta Merle, Christian Morath, Panagiota Zgoura, Rita Dittmer, Sonja Schneppenheim, Jochen Wilhelm, Nina Babel, Ulrich Budde, and Timm H. Westhoff
- Subjects
Medicine ,Science - Abstract
Abstract Ubiquitous microthromboses in the pulmonary vasculature play a crucial role in the pathogenesis of COVID-19 associated acute respiratory distress syndrome (ARDS). Excess of Willebrand factor (vWf) with intravascular multimer formation was identified as a key driver of this finding. Plasma exchange (PLEX) might be a therapeutic option to restore the disbalance between vWf and ADAMTS13. We report the effects of PLEX on vWf, ADAMTS13, inflammatory cytokines and parameters of ventilation. We investigated 25 patients, who were on mechanical ventilation for COVID-19 pneumonia with ARDS at two German university hospitals. All patients received PLEX as an ultima ratio measure for refractory ARDS. VWf antigen (vWf:Ag), ADAMTS13 activity, a cytokine panel mirroring the inflammatory situation and clinical parameters were assessed before and after three to six PLEX therapies with fresh frozen plasma. Before the PLEX sequence there was an excessive release of vWf:Ag (425.4 ± 167.5%) and mildly reduced ADAMTS13 activity (49.7 ± 23.3%). After the PLEX series, there was a significant increase of ADAMTS13 activity to 62.4 ± 17.7% (p = 0.029) and a significant decrease of vWf:Ag to 336.1 ± 138.2% (p = 0.041) resulting in a 63% improvement of the ADAMT13/vWf:Ag ratio from 14.5 ± 10.0 to 23.7 ± 14.6, p = 0.024. Comparison of parameters before and after individual PLEX sessions (n = 35) revealed a mean reduction of vWf from 387.8 ± 165.1 to 213.2 ± 62.3% (p = 0.001) and an increase of ADAMTS13 activity from 60.4 ± 20.1 to 70.5 ± 14.0% (p = 0.001). Parallelly, monocyte chemotactic protein-1 and interleukin-18 decreased significantly (p = 0.034 each). Along the PLEX sequence lactate dehydrogenase (p = 0.001), C-reactive protein (p = 0.001), and positive end expiratory pressure (p = 0.01) significantly decreased accompanied by an improvement of Horovitz index (p = 0.001). PLEX restores the disbalance between ADAMTS13 and vWf:Ag, a driver of immunothrombosis. Moreover, it reduces the inflammatory state and is associated with a benefit of ventilation parameters. These findings render a further rationale to regard PLEX as a therapeutic option in severe COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
30. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
- Author
-
Stumpf, Julian, Siepmann, Torsten, Lindner, Tom, Karger, Claudia, Schwöbel, Jörg, Anders, Leona, Faulhaber-Walter, Robert, Schewe, Jens, Martin, Heike, Schirutschke, Holger, Barnett, Kerstin, Hüther, Jan, Müller, Petra, Langer, Torsten, Pluntke, Thilo, Anding-Rost, Kirsten, Meistring, Frank, Stehr, Thomas, Pietzonka, Annegret, Escher, Katja, Cerny, Simon, Rothe, Hansjörg, Pistrosch, Frank, Seidel, Harald, Paliege, Alexander, Beige, Joachim, Bast, Ingolf, Steglich, Anne, Gembardt, Florian, Kessel, Friederike, Kröger, Hannah, Arndt, Patrick, Sradnick, Jan, Frank, Kerstin, Klimova, Anna, Mauer, René, Grählert, Xina, Anft, Moritz, Blazquez-Navarro, Arturo, Westhoff, Timm H, Stervbo, Ulrik, Tonn, Torsten, Babel, Nina, and Hugo, Christian
- Published
- 2021
- Full Text
- View/download PDF
31. Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
- Author
-
Krystallenia Paniskaki, Margarethe J. Konik, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, Jasmin Jäger, Adalbert Krawczyk, Markus Zettler, Sebastian Dolff, Timm H. Westhoff, Hana Rohn, Ulrik Stervbo, Oliver Witzke, and Nina Babel
- Subjects
SARS-CoV-2 ,T cells ,neutralizing antibodies ,vaccine ,adaptive immunity ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Emerging variants of concern (VOC) raise obstacles in shaping vaccination strategies and ending the pandemic. Vaccinated SARS-CoV-2 convalescence shapes the current immune dynamics. We analyzed the SARS-CoV-2 VOC-specific cellular and humoral response of 57 adults: 42 convalescent mRNA vaccinated patients (C+V+), 8 uninfected mRNA vaccinated (C-V+) and 7 unvaccinated convalescent individuals (C+V-). While C+V+ demonstrated a superior humoral SARS-CoV-2 response against all analyzed VOC (alpha, delta, omicron) compared to C-V+ and C+V-, SARS-CoV-2 reactive CD4+ and CD8+ T cells, which can cross-recognize the alpha, delta and omicron VOC after infection and/or vaccination were observed in all there groups without significant differences between the groups. We observed a preserved cross-reactive C+V+ and C-V+ T cell memory. An inferior humoral response but preserved cross-reactive T cell memory in C+V- compared to C+V+ was observed, as well as an inferior humoral response but preserved cross-reactive T cell memory in C+V- compared to C-V+. Adaptive immunity generated after SARS-CoV-2 infection and vaccination leads to superior humoral immune response against VOC compared to isolated infection or vaccination. Despite the apparent loss of neutralization potential caused by viral evolution, a preserved SARS-CoV-2 reactive T cell response with a robust potential for cross-recognition of the alpha, delta and omicron VOC was detected in all studied cohorts. Our results may have implications on current vaccination strategies.
- Published
- 2022
- Full Text
- View/download PDF
32. Prevalence of masked hypertension in attended versus unattended office blood pressure measurement.
- Author
-
Bertram, Sebastian, Bauer, Frederic, Shadi, Roni, Seidel, Maximilian, Doevelaar, Adrian, Seibert, Felix, Babel, Nina, and Westhoff, Timm H.
- Abstract
There is a controversial debate regarding whether unattended blood pressure (BP) measurement should be regarded as the new gold standard of office BP measurement. Unattended BP measurement eliminates the white‐coat effect and reduces external influences on the patient. On the other hand, it might underestimate real‐life BP. The present study compares the prevalence of masked hypertension using attended versus unattended office BP measurements. We performed a cross‐sectional study on 213 patients in a general practitioner's outpatient clinic and compared attended and unattended office BP with 24h‐ambulatory BP monitoring (24h‐ABPM). Masked hypertension was defined as pressure ≥135/85 mmHg in daytime ABPM with office systolic BP < 140/90 mmHg. Median attended and unattended office BPs were 140/86 and 134/80 mmHg with a median 24h‐BP of 129/79 mmHg and daytime ABP of 133/82 mmHg. The number of patients with masked hypertension was 45/213 (21.2%) using unattended and 23/213 (10.8%) using attended office BP measurements (p <.0001). Bland–Altman analysis revealed a 7.4 mmHg systolic and 6.2 mmHg diastolic bias between the attended versus unattended office BP, and two systolic and −1.7 mmHg diastolic biases between the unattended office BP and daytime ambulatory BP. In linear regression analysis, an unattended office BP of 134 mmHg corresponded to 140 mmHg in attended BP measurement. Using a cut‐off of 135/85 mmHg instead of 140/90 mmHg in unattended office BP measurement, the rate of masked hypertension was 26/213 (12.2%). Thus, unattended office BP measurement results in a substantial increase in the prevalence of masked hypertension using the traditional definition of hypertension. The present findings suggest that it might be reasonable to use a definition of 135/85 mmHg. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases
- Author
-
Felix S. Seibert, Maximilian Sitz, Jürgen Passfall, Martin Haesner, Peter Laschinski, Martin Buhl, Frederic Bauer, Benjamin Rohn, Nina Babel, and Timm H. Westhoff
- Subjects
calprotectin ,chronic kidney disease ,kim-1 ,ngal ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Introduction It has been demonstrated that urinary neutrophil gelatinase-associated lipocalin (NGAL) and calprotectin are helpful biomarkers in the differentiation of intrinsic and prerenal acute kidney injury. Objective The present cross-sectional study investigates, whether urinary biomarkers are able to differentiate primarily inflammatory from non-inflammatory entities in chronic kidney disease (CKD). Methods Urinary calprotectin, NGAL, and kidney injury molecule-1 (KIM-1) concentrations were assessed in a study population of 143 patients with stable CKD and 29 healthy controls. Stable renal function was defined as an eGFR fluctuation ≤5 ml/min/1.73 m2 in the past 12 months. Pyuria, metastatic carcinoma, and renal transplantation were regarded as exclusion criteria. Diabetic nephropathy, hypertensive nephropathy, and polycystic kidney disease were categorized as ‘primarily non-inflammatory renal diseases’ (NIRD), whereas glomerulonephritis and vasculitis were regarded as ‘primarily inflammatory renal diseases’ (IRD). Results Urinary calprotectin and NGAL concentrations significantly differed between CKD and healthy controls (p 0.05 each). Albumin exceeds the diagnostic power of the investigated biomarkers by far. Conclusions The urinary biomarkers calprotectin, NGAL, and KIM-1 have no diagnostic value in the differentiation of primarily inflammatory vs. non-inflammatory etiologies of CKD.
- Published
- 2021
- Full Text
- View/download PDF
34. Detection of SARS-CoV-2 pneumonia: two case reports
- Author
-
Felix S. Seibert, Daniela Toma, Frederic Bauer, Krystallenia Paniskaki, Moritz Anft, Benjamin J. Rohn, Simon Wang, Diana Racovitan, Nina Babel, and Timm H. Westhoff
- Subjects
COVID-19 ,SARS-CoV-2 ,Swab test ,Medicine - Abstract
Abstract Background Developing therapeutic strategies for a SARS-CoV-2 infection is challenging, but first the correct diagnosis has to be made. Unspecific upper and lower respiratory tract symptoms can be misleading; hence, a nasopharyngeal swab test with a real-time reverse-transcription-polymerase chain reaction is of great importance. However, early viral clearing jeopardizes a sound diagnosis of COVID-19. Case presentation We report on two Caucasian patients who had negative pharyngeal swab tests at the onset of SARS-CoV-2 pneumonia. In one patient, the virus was not even detectable in bronchoalveolar lavage despite typical radiomorphologic changes. Conclusions Negative PCR findings in both the pharynx and bronchoalveolar lavage do not exclude COVID-19 pneumonia. Computed tomography is a crucial diagnostic prerequisite in this context.
- Published
- 2020
- Full Text
- View/download PDF
35. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
- Author
-
Thieme, Constantin J., Anft, Moritz, Paniskaki, Krystallenia, Blazquez-Navarro, Arturo, Doevelaar, Adrian, Seibert, Felix S., Hoelzer, Bodo, Konik, Margarethe Justine, Berger, Marc Moritz, Brenner, Thorsten, Tempfer, Clemens, Watzl, Carsten, Meister, Toni L., Pfaender, Stephanie, Steinmann, Eike, Dolff, Sebastian, Dittmer, Ulf, Westhoff, Timm H., Witzke, Oliver, Stervbo, Ulrik, Roch, Toralf, and Babel, Nina
- Published
- 2020
- Full Text
- View/download PDF
36. ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
- Author
-
Völker, Linus A., Kaufeld, Jessica, Miesbach, Wolfgang, Brähler, Sebastian, Reinhardt, Martin, Kühne, Lucas, Mühlfeld, Anja, Schreiber, Adrian, Gaedeke, Jens, Tölle, Markus, Jabs, Wolfram J., Özcan, Fedai, Markau, Silke, Girndt, Matthias, Bauer, Frederic, Westhoff, Timm H., Felten, Helmut, Hausberg, Martin, Brand, Marcus, Gerth, Jens, Bieringer, Markus, Bommer, Martin, Zschiedrich, Stefan, Schneider, Johanna, Elitok, Saban, Gawlik, Alexander, Gäckler, Anja, Kribben, Andreas, Schwenger, Vedat, Schoenermarck, Ulf, Roeder, Maximilian, Radermacher, Jörg, Bramstedt, Jörn, Morgner, Anke, Herbst, Regina, Harth, Ana, Potthoff, Sebastian A., von Auer, Charis, Wendt, Ralph, Christ, Hildegard, Brinkkoetter, Paul T., and Menne, Jan
- Published
- 2020
- Full Text
- View/download PDF
37. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
- Author
-
Völker, Linus A., Kaufeld, Jessica, Miesbach, Wolfgang, Brähler, Sebastian, Reinhardt, Martin, Kühne, Lucas, Mühlfeld, Anja, Schreiber, Adrian, Gaedeke, Jens, Tölle, Markus, Jabs, Wolfram J., Özcan, Fedai, Markau, Silke, Girndt, Matthias, Bauer, Frederic, Westhoff, Timm H., Felten, Helmut, Hausberg, Martin, Brand, Marcus, Gerth, Jens, Bieringer, Markus, Bommer, Martin, Zschiedrich, Stefan, Schneider, Johanna, Elitok, Saban, Gawlik, Alexander, Gäckler, Anja, Kribben, Andreas, Schwenger, Vedat, Schoenermarck, Ulf, Roeder, Maximilian, Radermacher, Jörg, Bramstedt, Jörn, Morgner, Anke, Herbst, Regina, Harth, Ana, Potthoff, Sebastian A., von Auer, Charis, Wendt, Ralph, Christ, Hildegard, Brinkkoetter, Paul T., and Menne, Jan
- Published
- 2020
- Full Text
- View/download PDF
38. Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
- Author
-
Benjamin Rohn, Wiebke Jansing, Felix S. Seibert, Thiemo Pfab, Okan Cinkilic, Jürgen Paßfall, Sven Schmidt, Nina Babel, Frederic Bauer, and Timm H. Westhoff
- Subjects
chronic kidney disease ,hyperuricemia ,hemodialysis ,mortality ,gout ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Introduction In the general population, hyperuricemia is associated with increased morbidity and mortality. Data on this association in hemodialysis patients is controversial. Moreover, it remains elusive whether serum uric acid (SUA) lowering therapy is associated with mortality. Methods Retrospective analysis of 601 patients on chronic hemodialysis therapy in five outpatient centers with a maximum follow-up of 100 and a mean follow-up of 41 months. Death was defined as primary endpoint. Cumulative survival was analyzed by Kaplan–Meier analysis and Cox regressions adjusted for age. Findings Cumulative survival rates were higher for those subjects with a higher than median SUA concentration both based on mean annual and baseline measurements (p 0.05 each). Stratification for SUA lowering therapy (allopurinol/febuxostat) had no impact on cumulative survival, neither in Kaplan Meier nor in Cox regression analyses (p > 0.05 each). Furthermore, Cox regression analysis excluded an increased cardiovascular mortality in subjects with hyperuricemia. Discussion In contrast to the general population, hyperuricemia is not associated with increased mortality in patients undergoing hemodialysis. Moreover, xanthine oxidase inhibition was not associated with a survival benefit in this analysis. These data do not support the use of SUA lowering medication in hemodialysis patients with asymptomatic hyperuricemia.
- Published
- 2020
- Full Text
- View/download PDF
39. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
- Author
-
Krystallenia Paniskaki, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, Sarah Skrzypczyk, Felix S. Seibert, Constantin J. Thieme, Margarethe J. Konik, Sebastian Dolff, Olympia Anastasiou, Bodo Holzer, Ulf Dittmer, Christine Queren, Lutz Fricke, Hana Rohn, Timm H. Westhoff, Oliver Witzke, Ulrik Stervbo, Toralf Roch, and Nina Babel
- Subjects
SARS-CoV-2 ,vaccine ,mRNA ,breakthrough infection ,T cells ,neutralizing antibodies ,Immunologic diseases. Allergy ,RC581-607 - Abstract
SARS-CoV-2 variants of concern (VOCs) can trigger severe endemic waves and vaccine breakthrough infections (VBI). We analyzed the cellular and humoral immune response in 8 patients infected with the alpha variant, resulting in moderate to fatal COVID-19 disease manifestation, after double mRNA-based anti-SARS-CoV-2 vaccination. In contrast to the uninfected vaccinated control cohort, the diseased individuals had no detectable high-avidity spike (S)-reactive CD4+ and CD8+ T cells against the alpha variant and wild type (WT) at disease onset, whereas a robust CD4+ T-cell response against the N- and M-proteins was generated. Furthermore, a delayed alpha S-reactive high-avidity CD4+ T-cell response was mounted during disease progression. Compared to the vaccinated control donors, these patients also had lower neutralizing antibody titers against the alpha variant at disease onset. The delayed development of alpha S-specific cellular and humoral immunity upon VBI indicates reduced immunogenicity against the S-protein of the alpha VOC, while there was a higher and earlier N- and M-reactive T-cell response. Our findings do not undermine the current vaccination strategies but underline a potential need for the inclusion of VBI patients in alternative vaccination strategies and additional antigenic targets in next-generation SARS-CoV-2 vaccines.
- Published
- 2022
- Full Text
- View/download PDF
40. Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study
- Author
-
Wolfgang Miesbach, Jan Menne, Martin Bommer, Ulf Schönermarck, Thorsten Feldkamp, Martin Nitschke, Timm H. Westhoff, Felix S. Seibert, Rainer Woitas, Rui Sousa, Michael Wolf, Stefan Walzer, and Björn Schwander
- Subjects
Epidemiology ,Germany ,Incidence ,Thrombotic microangiopathy ,Thrombotic thrombocytopenic purpura ,Medicine - Abstract
Abstract Background Acquired thrombotic thrombocytopenic Purpura (aTTP) is a life-threatening ultra-orphan disease with a reported annual incidence between 1.5 and 6.0 cases per million in Europe and mainly affecting otherwise young and healthy adults aged 40 years on average. The goal of this study was to assess the incidence of aTTP in Germany. Methods A systematic review was performed to determine the published evidence on the aTTP epidemiology in Germany. To obtain additional evidence on the proportion of aTTP cases within the national Thrombotic Microangiopathy (TMA) population a hospital-level study was performed, using a retrospective data collection approach. Diagnosis of aTTP was confirmed if ADAMTS13 level were
- Published
- 2019
- Full Text
- View/download PDF
41. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
- Author
-
Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann, Benedikt Kolbrink, Kevin Schulte, Anja Gäckler, Andreas Kribben, Kristina Boss, Sebastian A. Potthoff, Lars C. Rump, Tilman Schmidt, Anja S. Mühlfeld, Karsten Schulmann, Matthias Hermann, Jens Gaedeke, Kristin Sauerland, Jörn Bramstedt, Ulrich P. Hinkel, Wolfgang Miesbach, Frederic Bauer, Timm H. Westhoff, Heike Bruck, Veronika Buxhofer-Ausch, Tobias J. Müller, Ralph Wendt, Ana Harth, Adrian Schreiber, Evelyn Seelow, Markus Tölle, Christopher Gohlisch, Markus Bieringer, Gesa Geuther, Wolfram J. Jabs, Michael Fischereder, Anke von Bergwelt-Baildon, Ulf Schönermarck, Paul Knoebl, Jan Menne, Paul T. Brinkkoetter, Fedai Özcan, Silke Markau, Matthias Girndt, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Vedat Schwenger, Maximilian Roeder, Jörg Radermacher, Anke Morgner, Regina Herbst, and Charis von Auer
- Subjects
Medizin ,Hematology - Abstract
BACKGROUND: The von Willebrand factor-directed nanobody caplacizumab has greatly changed the treatment of immune thrombotic thrombocytopenic purpura (iTTP) in recent years. Data from randomized controlled trials established efficacy and safety. OBJECTIVES: This study aims to address open questions regarding patient selection, tailoring of therapy duration, obstacles in prescribing caplacizumab in iTTP, effect on adjunct treatment, and outcomes in the real-world setting. METHODS: We report retrospective, observational cohorts of 113 iTTP episodes treated with caplacizumab and 119 historical control episodes treated without caplacizumab. We aggregated data from the caplacizumab phase II/III trials and real-world data from France, the United Kingdom, Germany, and Austria (846 episodes, 396 treated with caplacizumab, and 450 historical controls). RESULTS: Caplacizumab was efficacious in iTTP, independent of the timing of therapy initiation, but curtailed the time of active iTTP only when used in the first-line therapy within 72 hours after diagnosis and until at least partial ADAMTS13-activity remission. Aggregated data from multiple study populations showed that caplacizumab use resulted in significant absolute risk reduction of 2.87% for iTTP-related mortality (number needed to treat 35) and a relative risk reduction of 59%. CONCLUSION: Caplacizumab should be used in first line and until ADAMTS13-remission, lowers iTTP-related mortality and refractoriness, and decreases the number of daily plasma exchange and hospital stay. This trial is registered at www. CLINICALTRIALS: gov as #NCT04985318.
- Published
- 2023
42. Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients
- Author
-
Arturo Blazquez-Navarro, Chantip Dang-Heine, Chris Bauer, Nicole Wittenbrink, Kerstin Wolk, Robert Sabat, Oliver Witzke, Timm H. Westhoff, Birgit Sawitzki, Petra Reinke, Oliver Thomusch, Christian Hugo, Nina Babel, and Michal Or-Guil
- Subjects
prevention ,valganciclovir ,gender ,graft function ,cytomegalovirus ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Post-transplantation cytomegalovirus (CMV) syndrome can be prevented using the antiviral drug (val)ganciclovir. (Val)ganciclovir is typically administered following a prophylactic or a pre-emptive strategy. The prophylactic strategy entails early universal administration, the pre-emptive strategy, early treatment in case of infection. However, it is not clear which strategy is superior with respect to transplantation outcome; sex-specific effects of these prevention strategies are not known. We have retrospectively analyzed 540 patients from the multi-centre Harmony study along eight pre-defined visits: 308 were treated according to a prophylactic, 232 according to a pre-emptive strategy. As expected, we observed an association of prophylactic strategy with lower incidence of CMV syndrome, delayed onset and lower viral loads compared to the pre-emptive strategy. However, in female patients, the prophylactic strategy was associated with a strong impairment of glomerular filtration rate one year post-transplant (difference: −11.8 ± 4.3 ml min−1·1.73 m−2, p = 0.006). Additionally, we observed a tendency of higher incidence of acute rejection and severe BK virus reactivation in the prophylactic strategy group. While the prophylactic strategy was more effective for preventing CMV syndrome, our results suggest for the first time that the prophylactic strategy might lead to inferior transplantation outcomes in female patients, providing evidence for a strong association with sex. Further randomized controlled studies are necessary to confirm this potential negative effect.
- Published
- 2020
- Full Text
- View/download PDF
43. Urinary acute kidney injury biomarkers in very low-birth-weight infants on indomethacin for patent ductus arteriosus
- Author
-
Waldherr, Sina, Fichtner, Alexander, Beedgen, Bernd, Bruckner, Thomas, Schaefer, Franz, Tönshoff, Burkhard, Pöschl, Johannes, Westhoff, Timm H., and Westhoff, Jens H.
- Published
- 2019
- Full Text
- View/download PDF
44. Detection of SARS-CoV-2 pneumonia: two case reports
- Author
-
Seibert, Felix S., Toma, Daniela, Bauer, Frederic, Paniskaki, Krystallenia, Anft, Moritz, Rohn, Benjamin J., Wang, Simon, Racovitan, Diana, Babel, Nina, and Westhoff, Timm H.
- Published
- 2020
- Full Text
- View/download PDF
45. The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation
- Author
-
Bajda, Sharon, Blazquez-Navarro, Arturo, Samans, Björn, Wehler, Patrizia, Kaliszczyk, Sviatlana, Amini, Leila, Schmueck-Henneresse, Michael, Witzke, Oliver, Dittmer, Ulf, Westhoff, Timm H., Viebahn, Richard, Reinke, Petra, Thomusch, Oliver, Hugo, Christian, Olek, Sven, Roch, Toralf, and Babel, Nina
- Published
- 2020
- Full Text
- View/download PDF
46. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins
- Author
-
Stervbo, Ulrik, Rahmann, Sven, Roch, Toralf, Westhoff, Timm H., and Babel, Nina
- Published
- 2020
- Full Text
- View/download PDF
47. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
- Author
-
Constantin J. Thieme, Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez-Navarro, Adrian Doevelaar, Felix S. Seibert, Bodo Hoelzer, Margarethe Justine Konik, Marc Moritz Berger, Thorsten Brenner, Clemens Tempfer, Carsten Watzl, Toni L. Meister, Stephanie Pfaender, Eike Steinmann, Sebastian Dolff, Ulf Dittmer, Timm H. Westhoff, Oliver Witzke, Ulrik Stervbo, Toralf Roch, and Nina Babel
- Subjects
COVID-19 ,SARS-CoV-2 ,immunity ,spike ,nucleocapsid ,S/M/N protein-reactive T cells ,Medicine (General) ,R5-920 - Abstract
Summary: T cell immunity toward SARS-CoV-2 spike (S-), membrane (M-), and nucleocapsid (N-) proteins may define COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive T cell responses in moderate, severe, and critical COVID-19 patients and unexposed donors. Overlapping peptide pools of all three proteins induce SARS-CoV-2-reactive T cell response with dominance of CD4+ over CD8+ T cells and demonstrate interindividual immunity against the three proteins. M-protein induces the highest frequencies of CD4+ T cells, suggesting its relevance for diagnosis and vaccination. The T cell response of critical COVID-19 patients is robust and comparable or even superior to non-critical patients. Virus clearance and COVID-19 survival are not associated with either SARS-CoV-2 T cell kinetics or magnitude of T cell responses, respectively. Thus, our data do not support the hypothesis of insufficient SARS-CoV-2-reactive immunity in critical COVID-19. Conversely, it indicates that activation of differentiated memory effector T cells could cause hyperreactivity and immunopathogenesis in critical patients.
- Published
- 2020
- Full Text
- View/download PDF
48. Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
- Author
-
Felix S Seibert, Anja Heringhaus, Nikolaos Pagonas, Henrik Rudolf, Benjamin Rohn, Frederic Bauer, Nina Timmesfeld, Hans-Joachim Trappe, Nina Babel, and Timm H Westhoff
- Subjects
Medicine ,Science - Abstract
BackgroundSubjects with chronic kidney disease are at increased risk for contrast-induced acute kidney injury (CI-AKI). Risk stratification is traditionally based on glomerular filtration rate (GFR) and proteinuria. The present trial examines, whether tubular and inflammatory biomarkers are able to identify subjects at increased risk as well.MethodsWe performed a prospective study in 490 patients undergoing coronary angiography. An increase of serum creatinine concentration ≥ 0.3 mg/dl from baseline to day 2-3 was defined as primary endpoint (CI-AKI). Urinary neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and calprotectin were assessed < 24h before coronary angiography. Prognostic accuracy was assessed by receiver operating characteristics (ROC) calculations.Results30 (6.1%) patients suffered from CI-AKI (27 AKIN stage I, 3 AKIN stage II, 0 AKIN stage III). Those subjects who developed CI-AKI had 3.1 fold higher baseline urinary NGAL/creatinine ratios than those without CI-AKI (60.8 [IQR 18.7-93.1] μg/mg vs. 19.9 [IQR 12.3-38.9] μg/mg, p = 0.001). In those subjects without clinically overt CKD (eGFR > 60 ml/min, urinary albumin creatinine ratio 0.05 each). ROC analyses revealed an area under the curve (AUC) of 0.68 (95% CI 0.60-0.81) for NGAL/creatinine. An NGAL/creatinine ratio < 56.4 μg/mg has a negative predictive value of 96.5%.ConclusionsThe present study is the largest investigation on the use of urinary biomarkers for CI-AKI risk stratification so far. It shows that NGAL provides prognostic information beyond the glomerular biomarkers eGFR and proteinuria.
- Published
- 2020
- Full Text
- View/download PDF
49. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy
- Author
-
Julia Neuhaus, Frederic Bauer, Christina Fitzner, Ralf-Dieter Hilgers, Felix Seibert, Nina Babel, Adrian Doevelaar, Frank Eitner, Jürgen Floege, Thomas Rauen, and Timm H. Westhoff
- Subjects
IgA nephropathy ,NGAL ,KIM-1 ,[TIMP-2] ,[IGFBP7] ,Calprotectin ,Dermatology ,RL1-803 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Background/Aims: The addition of immunosuppression to supportive care reduces proteinuria in a subset of patients with IgA nephropathy (IgAN) but is associated with an increased rate of adverse events. The present work investigates whether urinary biomarkers are able to identify subjects who benefit from immunosuppression and to predict the progression of disease in a sub-cohort of the STOP-IgAN trial. Methods: Urinary neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), calprotectin, and the product of tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 (TIMP2•IGFBP7) were measured in all available urine samples obtained at the time point of enrollment in the STOP-IgAN trial (n=113). Results: Biomarker concentrations in both the overall study population and the subgroup with additional immunosuppression did not differ in subjects reaching vs. not reaching full clinical remission, eGFR loss ≥ 15, or 30 ml/min/1.73 m2 over the 3-year trial phase (p> 0.05 each). Receiver-operating characteristic curves showed a poor predictive accuracy of each biomarker for the above-mentioned parameters in the overall study population (areas under the curve ≤0.611). Accordingly, there was neither a significant correlation of any biomarker and adverse outcome in linear regression analysis, nor between biomarker concentrations at enrollment and change in the eGFR over the 3-year observation period. Conclusion: NGAL, KIM-1, calprotectin, and [TIMP-2]•[IGFBP7] had neither a prognostic value for the progression of IgAN, nor for the response to immunosuppression in the present sub-cohort of the STOP-IgAN trial. The search for appropriate biomarkers for an individualized treatment strategy in IgAN continues.
- Published
- 2018
- Full Text
- View/download PDF
50. BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre StudyResearch in context
- Author
-
Arturo Blazquez-Navarro, Chantip Dang-Heine, Nicole Wittenbrink, Chris Bauer, Kerstin Wolk, Robert Sabat, Timm H. Westhoff, Birgit Sawitzki, Petra Reinke, Oliver Thomusch, Christian Hugo, Michal Or-Guil, and Nina Babel
- Subjects
Medicine ,Medicine (General) ,R5-920 - Abstract
Background: BK virus (BKV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations are common after kidney transplantation and associated with increased morbidity and mortality. Although CMV might be a risk factor for BKV and EBV, the effects of combined reactivations remain unknown. The purpose of this study is to ascertain the interaction and effects on graft function of these reactivations. Methods: 3715 serum samples from 540 kidney transplant recipients were analysed for viral load by qPCR. Measurements were performed throughout eight visits during the first post-transplantation year. Clinical characteristics, including graft function (GFR), were collected in parallel. Findings: BKV had the highest prevalence and viral loads. BKV or CMV viral loads over 10,000 copies·mL−1 led to significant GFR impairment. 57 patients had BKV-CMV combined reactivation, both reactivations were significantly associated (p = 0.005). Combined reactivation was associated with a significant GFR reduction one year post-transplantation of 11.7 mL·min−1·1.73 m−2 (p = 0.02) at relatively low thresholds (BKV > 1000 and CMV > 4000 copies·mL−1). For EBV, a significant association was found with CMV reactivation (p = 0.02), but no GFR reduction was found. Long cold ischaemia times were a further risk factor for high CMV load. Interpretation: BKV-CMV combined reactivation has a deep impact on renal function one year post-transplantation and therefore most likely on long-term allograft function, even at low viral loads. Frequent viral monitoring and subsequent interventions for low BKV and/or CMV viraemia levels and/or long cold ischaemia time are recommended. Fund: Investigator Initiated Trial; financial support by German Federal Ministry of Education and Research (BMBF). Keywords: BK virus, Cytomegalovirus, Epstein-Barr virus, Kidney transplantation, Graft function, Combined reactivation
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.